However, a recent study found linkage between two SNPs located on the 22nd chromosome (chr22:29203724:C/T and chr22:29551872:A/G) and the CHEK2 c.1100delC variant, and therefore using PRS313 would result in an overestimation of BC risk in heterozygotes. This evidence concerns the gene CHEK2 and breast cancer.